SBIO Fundamental Analysis - SABIO HOLDINGS INC

Fundamental Rating

Overall SBIO gets a fundamental rating of 4 out of 10. We evaluated SBIO against 11 industry peers in the Media industry. Both the profitability and financial health of SBIO have multiple concerns. SBIO is growing strongly while it is still valued neutral. This is a good combination!

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SBIO was profitable.

In the past year SBIO had a positive cash flow from operations.

SBIO had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: SBIO reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.42%, SBIO is in line with its industry, outperforming 58.33% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-2.42%
ROE	N/A
ROIC	N/A

ROA(3y)-9.32%

ROA(5y)-8.06%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 3.59%, SBIO is in the better half of the industry, outperforming 66.67% of the companies in the same industry.

In the last couple of years the Operating Margin of SBIO has grown nicely.

SBIO has a Gross Margin of 61.95%. This is amongst the best in the industry. SBIO outperforms 91.67% of its industry peers.

SBIO's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	3.59%
PM (TTM)	N/A
GM	61.95%

OM growth 3Y45.05%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.9%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SBIO does not have a ROIC to compare to the WACC, probably because it is not profitable.

SBIO has more shares outstanding than it did 1 year ago.

SBIO has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.20 indicates that SBIO is not a great score, but indicates only limited risk for bankruptcy at the moment.

SBIO has a better Altman-Z score (2.20) than 100.00% of its industry peers.

The Debt to FCF ratio of SBIO is 3.48, which is a good value as it means it would take SBIO, 3.48 years of fcf income to pay off all of its debts.

With a decent Debt to FCF ratio value of 3.48, SBIO is doing good in the industry, outperforming 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	3.48
Altman-Z	2.2

ROIC/WACCN/A

WACC7.16%

2.3 Liquidity

SBIO has a Current Ratio of 0.67. This is a bad value and indicates that SBIO is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of SBIO (0.67) is worse than 75.00% of its industry peers.

SBIO has a Quick Ratio of 0.67. This is a bad value and indicates that SBIO is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.67, SBIO is doing worse than 75.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.67
Quick Ratio	0.67

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.60% over the past year.

Looking at the last year, SBIO shows a very strong growth in Revenue. The Revenue has grown by 46.10%.

SBIO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.99% yearly.

EPS 1Y (TTM)90.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)46.1%

Revenue growth 3Y26.99%

Revenue growth 5YN/A

Sales Q2Q%43.08%

3.2 Future

The Earnings Per Share is expected to grow by 124.72% on average over the next years. This is a very strong growth

Based on estimates for the next years, SBIO will show a quite strong growth in Revenue. The Revenue will grow by 12.64% on average per year.

EPS Next Y-150.5%

EPS Next 2Y124.72%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year10.41%

Revenue Next 2Y12.64%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 40.50, SBIO can be considered very expensive at the moment.

SBIO's Price/Earnings ratio is a bit cheaper when compared to the industry. SBIO is cheaper than 66.67% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 27.24, SBIO is valued a bit more expensive.

SBIO is valuated cheaply with a Price/Forward Earnings ratio of 5.76.

Based on the Price/Forward Earnings ratio, SBIO is valued cheaper than 100.00% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.81. SBIO is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	40.5
Fwd PE	5.76

4.2 Price Multiples

SBIO's Enterprise Value to EBITDA ratio is in line with the industry average.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBIO is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	6.21
EV/EBITDA	6.96

4.3 Compensation for Growth

A more expensive valuation may be justified as SBIO's earnings are expected to grow with 124.72% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y124.72%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SBIO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SABIO HOLDINGS INC

TSX-V:SBIO (8/21/2025, 7:00:00 PM)

0.405

0 (-1.22%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)08-19 2025-08-19

Earnings (Next)11-17 2025-11-17

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners48.56%

Ins Owner ChangeN/A

Market Cap20.29M

Analysts85.71

Price Target1.26 (211.11%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-13.2%

Min EPS beat(2)-58.42%

Max EPS beat(2)32.01%

EPS beat(4)2

Avg EPS beat(4)-12.79%

Min EPS beat(4)-58.42%

Max EPS beat(4)32.01%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)2.92%

Min Revenue beat(2)1.42%

Max Revenue beat(2)4.43%

Revenue beat(4)4

Avg Revenue beat(4)4.89%

Min Revenue beat(4)1.42%

Max Revenue beat(4)11.08%

Revenue beat(8)5

Avg Revenue beat(8)-2.74%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-7.5%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-400%

EPS NY rev (1m)-116.67%

EPS NY rev (3m)-116.67%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-3.3%

Revenue NY rev (1m)3.92%

Revenue NY rev (3m)3.92%

Valuation

		Industry Rank	Sector Rank
PE	40.5
Fwd PE	5.76
P/S	0.28
P/FCF	6.21
P/OCF	6.02
P/B	N/A
P/tB	N/A
EV/EBITDA	6.96

EPS(TTM)0.01

EY2.47%

EPS(NY)0.07

Fwd EY17.35%

FCF(TTM)0.07

FCFY16.09%

OCF(TTM)0.07

OCFY16.61%

SpS1.45

BVpS-0.09

TBVpS-0.16

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.42%
ROE	N/A
ROCE	-119.91%
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	3.59%
PM (TTM)	N/A
GM	61.95%
FCFM	4.48%

ROA(3y)-9.32%

ROA(5y)-8.06%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y45.05%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.9%

GM growth 5YN/A

F-Score7

Asset Turnover3.23

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	3.48
Debt/EBITDA	0.59
Cap/Depr	8.93%
Cap/Sales	0.14%
Interest Coverage	250
Cash Conversion	89.07%
Profit Quality	N/A
Current Ratio	0.67
Quick Ratio	0.67
Altman-Z	2.2

F-Score7

WACC7.16%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)90.6%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

EPS Next Y-150.5%

EPS Next 2Y124.72%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)46.1%

Revenue growth 3Y26.99%

Revenue growth 5YN/A

Sales Q2Q%43.08%

Revenue Next Year10.41%

Revenue Next 2Y12.64%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y166.95%

EBIT growth 3Y84.2%

EBIT growth 5YN/A

EBIT Next Year88.07%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y236.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y247.08%

OCF growth 3YN/A

OCF growth 5YN/A

SABIO HOLDINGS INC (SBIO.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens